CVS Drug Buyers Face Skeptical 9th Circ. In $121M Retrial Bid

By Dorothy Atkins (November 15, 2022, 8:32 PM EST) -- A certified class of insured drug buyers urged the Ninth Circuit on Tuesday to order a new trial after losing claims CVS Pharmacy owes $121 million for overcharging on generic drugs, arguing the trial judge erred in limiting their theories of liability and issuing a lengthy jury instruction on third-party beneficiaries....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!